{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T23:23:10Z","timestamp":1777072990598,"version":"3.51.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T00:00:00Z","timestamp":1559088000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T00:00:00Z","timestamp":1559088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["PDF\/2016\/002340"],"award-info":[{"award-number":["PDF\/2016\/002340"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13023-019-1093-6","type":"journal-article","created":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T14:03:19Z","timestamp":1559138599000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["The role of patient organizations in the rare disease ecosystem in India: an interview based study"],"prefix":"10.1186","volume":"14","author":[{"given":"Mohua Chakraborty","family":"Choudhury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2410-1431","authenticated-orcid":false,"given":"Gayatri","family":"Saberwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,29]]},"reference":[{"key":"1093_CR1","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1046\/j.1365-2516.2002.00643.x","volume":"8","author":"A Lavandeira","year":"2002","unstructured":"Lavandeira A. Orphan drugs: legal aspects, current situation. Haemophilia. 2002;8:194\u20138.","journal-title":"Haemophilia"},{"key":"1093_CR2","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.jval.2015.05.008","volume":"18","author":"T Richter","year":"2015","unstructured":"Richter T, Nestler-Parr S, Babela R, Khan ZM, Tesoro T, Molsen E, et al. Rare Disease Terminology and Definitions-A Systematic Global Review: Report of the ISPOR Rare Disease Special Interest Group. Value Health. 2015;18:906\u201314.","journal-title":"Value Health"},{"key":"1093_CR3","doi-asserted-by":"crossref","unstructured":"Valdez R, Ouyang L, Bolen J. Public Health and Rare Diseases: Oxymoron No More. Prev Chronic Dis. 2016;13:\u2013E05.","DOI":"10.5888\/pcd13.150491"},{"key":"1093_CR4","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1002\/ajmg.a.33380","volume":"152A","author":"JS Cohen","year":"2010","unstructured":"Cohen JS, Biesecker BB. Quality of life in rare genetic conditions: a systematic review of the literature. Am J Med Genet A. 2010;152A:1136\u201356.","journal-title":"Am J Med Genet A"},{"key":"1093_CR5","first-page":"123","volume":"21","author":"BS Verma","year":"1967","unstructured":"Verma BS. Ainhum. A rare disease. Indian J Med Sci. 1967;21:123\u20135.","journal-title":"Indian J Med Sci"},{"key":"1093_CR6","unstructured":"National Policy for Treatment of Rare Diseases. 2017. Available from: \n                    https:\/\/mohfw.gov.in\/sites\/default\/files\/Rare%20Diseases%20Policy%20FINAL.pdf\n                    \n                  . Accessed 17 Dec 2018."},{"key":"1093_CR7","doi-asserted-by":"publisher","first-page":"e009","DOI":"10.1017\/S0016672314000111","volume":"96","author":"HK Rajasimha","year":"2014","unstructured":"Rajasimha HK, Shirol PB, Ramamoorthy P, Hegde M, Barde S, Chandru V, et al. Organization for rare diseases India (ORDI) - addressing the challenges and opportunities for the Indian rare diseases\u2019 community. Genet Res. 2014;96:e009.","journal-title":"Genet Res"},{"key":"1093_CR8","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s12038-012-9256-9","volume":"37","author":"R Tamang","year":"2012","unstructured":"Tamang R, Singh L, Thangaraj K. Complex genetic origin of Indian populations and its implications. J Biosci. 2012;37:911\u20139.","journal-title":"J Biosci"},{"key":"1093_CR9","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1159\/000066335","volume":"5","author":"IC Verma","year":"2002","unstructured":"Verma IC, Bijarnia S. The burden of genetic disorders in India and a framework for community control. Community Genet. 2002;5:192\u20136.","journal-title":"Community Genet"},{"key":"1093_CR10","first-page":"1183","volume":"82","author":"S Bhattacharya","year":"2016","unstructured":"Bhattacharya S, Katoch VM, Majumder PP, Bhattacharya A. Rare Diseases In India: Current Knowledge and New Possibilities. Proc Indian Natl Sci Acad. 2016;82:1183\u20137.","journal-title":"Proc Indian Natl Sci Acad"},{"key":"1093_CR11","doi-asserted-by":"publisher","first-page":"267","DOI":"10.4103\/ijp.IJP_646_17","volume":"49","author":"H Kumar","year":"2017","unstructured":"Kumar H, Sarma P, Medhi B. Orphan drugs: Indian perspective. Indian J Pharmacol. 2017;49:267\u20139.","journal-title":"Indian J Pharmacol"},{"key":"1093_CR12","unstructured":"A comparative study of orphan drugs in US, EU & India. Pharmabiz.com. 2018. Available from \n                    http:\/\/pharmabiz.com\/NewsDetails.aspx?aid=108801&sid=21\n                    \n                  . Accessed 16 Dec 2018."},{"key":"1093_CR13","volume-title":"GST makes \u201corphan drugs\u201d prices soar","author":"R Mukherjee","year":"2017","unstructured":"Mukherjee R. GST makes \u201corphan drugs\u201d prices soar. 2017.Available from: \n                    https:\/\/timesofindia.indiatimes.com\/business\/india-business\/gst-makes-orphan-drugs-prices-soar\/articleshow\/61775207.cms\n                    \n                  . Accessed 18 Dec 2018."},{"key":"1093_CR14","unstructured":"Meyers AS. Orphan Drugs A Global Crusade. 2017. Available from: \n                    https:\/\/www.abbeysmeyers.com\/pdf\/Orphan-Drugs-A-Global-Crusade_Abbey-S-Meyers.pdf\n                    \n                  . Accessed 16 Dec 2018."},{"key":"1093_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13023-017-0618-0","volume":"12","author":"S Dharssi","year":"2017","unstructured":"Dharssi S, Wong-Rieger D, Harold M, Terry S. Review of 11 national policies for rare diseases in the context of key patient needs. Orphanet J Rare Dis. 2017;12:63.","journal-title":"Orphanet J Rare Dis."},{"key":"1093_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/009286150103500101","volume":"35","author":"DL Scott","year":"2001","unstructured":"Scott DL, Alder S, Usui E, Lui K. Orphan Drug Programs\/Policies in Australia, Japan, and Canada. Drug Inf J. 2001;35:1\u201316.","journal-title":"Drug Inf J."},{"key":"1093_CR17","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s13023-017-0738-6","volume":"12","author":"A Young","year":"2017","unstructured":"Young A, Menon D, Street J, Al-Hertani W, Stafinski T. Exploring patient and family involvement in the lifecycle of an orphan drug: a scoping review. Orphanet J Rare Dis. 2017;12:188.","journal-title":"Orphanet J Rare Dis."},{"key":"1093_CR18","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/978-3-319-67144-4_31","volume":"1031","author":"D Mascalzoni","year":"2017","unstructured":"Mascalzoni D, Petrini C, Taruscio D, Gainotti S. The Role of Solidarity(\u2212ies) in Rare Diseases Research. Adv Exp Med Biol. 2017;1031:589\u2013604.","journal-title":"Adv Exp Med Biol."},{"key":"1093_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40900-017-0065-z","volume":"3","author":"K Mikami","year":"2017","unstructured":"Mikami K, Sturdy S. Patient organization involvement and the challenge of securing access to treatments for rare diseases: report of a policy engagement workshop. Res Involv Engagem. 2017;3:14.","journal-title":"Res Involv Engagem."},{"key":"1093_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nrg1991","volume":"8","author":"SF Terry","year":"2007","unstructured":"Terry SF, Terry PF, Rauen KA, Uitto J, Bercovitch LG. Science and society: Advocacy groups as research organizations: the PXE International example. Nat Rev Genet. 2007;8:157.","journal-title":"Nat Rev Genet."},{"key":"1093_CR21","volume-title":"Finding a Cure: Incentivizing Partnerships Between Disease Advocacy Groups and Academic and Commercial Researchers","author":"A Readel","year":"2013","unstructured":"Readel A. Finding a Cure: Incentivizing Partnerships Between Disease Advocacy Groups and Academic and Commercial Researchers. 2013. Available from: \n                    https:\/\/papers.ssrn.com\/abstract=2349415"},{"key":"1093_CR22","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1146\/annurev-genom-091212-153525","volume":"14","author":"PP Koay","year":"2013","unstructured":"Koay PP, Sharp RR. The role of patient advocacy organizations in shaping genomic science. Annu Rev Genomics Hum Genet. 2013;14:579\u201395.","journal-title":"Annu Rev Genomics Hum Genet."},{"issue":"Suppl 3","key":"1093_CR23","doi-asserted-by":"publisher","first-page":"S788","DOI":"10.1007\/s11606-014-2895-9","volume":"29","author":"LP Forsythe","year":"2014","unstructured":"Forsythe LP, Szydlowski V, Murad MH, Ip S, Wang Z, Elraiyah TA, et al. A systematic review of approaches for engaging patients for research on rare diseases. J Gen Intern Med. 2014;29(Suppl 3):S788\u2013800.","journal-title":"J Gen Intern Med."},{"key":"1093_CR24","doi-asserted-by":"publisher","first-page":"A37","DOI":"10.1186\/1750-1172-7-S2-A37","volume":"7","author":"NT Sireau","year":"2012","unstructured":"Sireau NT. Developing a cure for Black Bone Disease. Orphanet J Rare Dis. 2012;7:A37.","journal-title":"Orphanet J Rare Dis."},{"key":"1093_CR25","unstructured":"McGrory B. Driven by loss, father inspires tireless pursuit of a cure. Boston Globe. 2012; Available from: \n                    http:\/\/www.bumc.bu.edu\/gms\/files\/2012\/02\/Driven-by-loss.pdf\n                    \n                  ."},{"key":"1093_CR26","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S2213-2600(13)70173-5","volume":"1","author":"R Akkermans","year":"2013","unstructured":"Akkermans R. Patient groups drive research for lymphangiomyomatosis. Lancet Respir Med. 2013;1:443\u20134.","journal-title":"Lancet Respir Med."},{"key":"1093_CR27","volume-title":"The Cure. Penguin Random House India Private Limited","author":"G Anand","year":"2010","unstructured":"Anand G. The Cure. Penguin Random House India Private Limited; 2010."},{"key":"1093_CR28","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13023-016-0382-6","volume":"11","author":"D Pinto","year":"2016","unstructured":"Pinto D, Martin D, Chenhall R. The involvement of patient organisations in rare disease research: a mixed methods study in Australia. Orphanet J Rare Dis. 2016;11:2.","journal-title":"Orphanet J Rare Dis."},{"key":"1093_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2796.2006.01666.x","volume":"260","author":"M W\u00e4stfelt","year":"2006","unstructured":"W\u00e4stfelt M, Fadeel B, Henter J-I. A journey of hope: lessons learned from studies on rare diseases and orphan drugs. J Intern Med. 2006;260:1\u201310.","journal-title":"J Intern Med."},{"key":"1093_CR30","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1016\/S0140-6736(08)60875-2","volume":"371","author":"S Aym\u00e9","year":"2008","unstructured":"Aym\u00e9 S, Kole A, Groft S. Empowerment of patients: lessons from the rare diseases community. Lancet. 2008;371:2048\u201351.","journal-title":"Lancet."},{"key":"1093_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s12687-012-0114-0","volume":"4","author":"D Mohanty","year":"2013","unstructured":"Mohanty D, Colah RB, Gorakshakar AC, Patel RZ, Master DC, Mahanta J, et al. Prevalence of \u03b2-thalassemia and other haemoglobinopathies in six cities in India: a multicentre study. J Community Genet. 2013;4:33\u201342.","journal-title":"J Community Genet."},{"key":"1093_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3233\/JND-170270","volume":"5","author":"S Bhattacharya","year":"2018","unstructured":"Bhattacharya S, Khadilkar SV, Nalini A, Ganapathy A, Mannan AU, Majumder PP, et al. Mutation Spectrum of GNE Myopathy in the Indian Sub-Continent. J Neuromuscul Dis. 2018;5:85\u201392.","journal-title":"J Neuromuscul Dis."},{"key":"1093_CR33","first-page":"169","volume":"1","author":"T Hamblin","year":"2008","unstructured":"Hamblin T, Kaul S, Dalvi UA. Approaches to therapy for children in India with cerebral palsy. J Pediatr Rehabil Med. 2008;1:169\u201374.","journal-title":"J Pediatr Rehabil Med."},{"key":"1093_CR34","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/BF02723953","volume":"67","author":"IC Verma","year":"2000","unstructured":"Verma IC. Burden of genetic disorders in India. Indian J Pediatr. 2000;67:893\u20138.","journal-title":"Indian J Pediatr."},{"key":"1093_CR35","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4103\/jpgm.JPGM_41_18","volume":"64","author":"M Muranjan","year":"2018","unstructured":"Muranjan M, Karande S. Enzyme replacement therapy in India: Lessons and insights. J Postgrad Med. 2018;64:195\u20139.","journal-title":"J Postgrad Med."},{"key":"1093_CR36","unstructured":"ActivityReport2017.pdf. Available from: \n                    https:\/\/www.orpha.net\/orphacom\/cahiers\/docs\/GB\/ActivityReport2017.pdf"},{"key":"1093_CR37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2147\/ODRR.S41070","volume":"4","author":"M Dunkle","year":"2014","unstructured":"Dunkle M. A 30-year retrospective: National Organization for Rare Disorders, the Orphan Drug Act, and the role of rare disease patient advocacy groups. Orphan Drugs: Research & Reviews. 2014;4:19\u201327.","journal-title":"Orphan Drugs: Research & Reviews."},{"key":"1093_CR38","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1177\/0003122412458509","volume":"77","author":"RK Best","year":"2012","unstructured":"Best RK. Disease Politics and Medical Research Funding: Three Ways Advocacy Shapes Policy. Am Sociol Rev. 2012;77:780\u2013803.","journal-title":"Am Sociol Rev."},{"key":"1093_CR39","unstructured":"Suraksha P. Rare diseases policy still in draft state.; Available from: \n                    http:\/\/www.newindianexpress.com\/cities\/bengaluru\/2018\/dec\/01\/rare-diseases-policy-still-in-draft-state-1905784.html\n                    \n                  . Accessed 18 Dec 2018."},{"key":"1093_CR40","unstructured":"Centre files affidavit in Delhi HC to revise policy for rare diseases: India Today; 2018. Available from: \n                    https:\/\/www.indiatoday.in\/india\/story\/centre-files-affidavit-in-delhi-hc-to-revise-policy-for-rare-diseases-1412694-2018-12-19\n                    \n                  . Accessed 19 Jan 2019."},{"key":"1093_CR41","unstructured":"After U-Turn on Rare Disease Policy, Health Ministry Assures New One in 9 Months. The Wire. 15 February 2019. Available from: \n                    https:\/\/thewire.in\/health\/india-rare-disease-policy\n                    \n                  . Accessed 20 Feb 2019."},{"key":"1093_CR42","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jval.2018.03.002","volume":"21","author":"S Auvin","year":"2018","unstructured":"Auvin S, Irwin J, Abi-Aad P, Battersby A. The Problem of Rarity: Estimation of Prevalence in Rare Disease. Value Health. 2018;21:501\u20137.","journal-title":"Value Health."},{"key":"1093_CR43","first-page":"28","volume":"6","author":"K Grow","year":"2014","unstructured":"Grow K, Vashist M, Abrol P, Sharma S, Yadav R. Beta thalassemia in India: current status and the challenges ahead. Int J Pharm Pharm Sci. 2014;6:28\u201333.","journal-title":"Int J Pharm Pharm Sci."},{"key":"1093_CR44","doi-asserted-by":"publisher","first-page":"e2417","DOI":"10.1136\/bmj.e2417","volume":"344","author":"CM Taylor","year":"2012","unstructured":"Taylor CM, Karet Frankl FE. Developing a strategy for the management of rare diseases. BMJ. 2012;344:e2417.","journal-title":"BMJ."},{"key":"1093_CR45","unstructured":"Rare Disease Centers of Excellence - Blue Matter Consulting. Blue Matter Consulting. 2018. Available from: \n                    https:\/\/bluematterconsulting.com\/rare-disease-centers-of-excellence\/"},{"issue":"4","key":"1093_CR46","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0033-3549(04)50253-4","volume":"118","author":"Joseph R Betancourt","year":"2003","unstructured":"Betancourt JR, Green AR, Carrillo JE, Ananeh-Firempong O 2nd. Defining cultural competence: a practical framework for addressing racial\/ethnic disparities in health and health care. Public Health Rep. 2003;118:293\u2013302.","journal-title":"Public Health Reports"},{"key":"1093_CR47","doi-asserted-by":"publisher","first-page":"27106","DOI":"10.3402\/gha.v8.27106","volume":"8","author":"MC Arcaya","year":"2015","unstructured":"Arcaya MC, Arcaya AL, Subramanian SV. Inequalities in health: definitions, concepts, and theories. Glob Health Action. 2015;8:27106.","journal-title":"Glob Health Action."},{"key":"1093_CR48","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/aur.1431","volume":"8","author":"MP Mamidala","year":"2015","unstructured":"Mamidala MP, Kalikiri MK, Praveen Kumar PTV, Rajesh N, Vallamkonda OR, Rajesh V. Consanguinity in India and its association with autism spectrum disorder. Autism Res. 2015;8:224\u20138.","journal-title":"Autism Res."},{"key":"1093_CR49","doi-asserted-by":"publisher","first-page":"625721","DOI":"10.1155\/2015\/625721","volume":"2015","author":"R Kumar","year":"2015","unstructured":"Kumar R, Arya V, Agarwal S. Profiling \u03b2 Thalassemia Mutations in Consanguinity and Nonconsanguinity for Prenatal Screening and Awareness Programme. Adv Hematol. 2015;2015:625721.","journal-title":"Adv Hematol."},{"issue":"2","key":"1093_CR50","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00277-018-3536-x","volume":"98","author":"Sujana Biswas","year":"2018","unstructured":"Biswas S, Nag A, Ghosh K, Ray R, Roy K, Bandyopadhyay A, et al. Genetic determinants related to pharmacological induction of foetal haemoglobin in transfusion-dependent HbE-\u03b2 thalassaemia. Ann Hematol. 2018; Available from: \n                    https:\/\/doi.org\/10.1007\/s00277-018-3536-x\n                    \n                  .","journal-title":"Annals of Hematology"},{"key":"1093_CR51","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s12098-016-2267-z","volume":"84","author":"S Sharma","year":"2017","unstructured":"Sharma S, Seth B, Jawade P, Ingale M, Setia MS. Quality of Life in Children with Thalassemia and their Caregivers in India. Indian J Pediatr. 2017;84:188\u201394.","journal-title":"Indian J Pediatr."},{"key":"1093_CR52","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.pediatrneurol.2017.01.010","volume":"70","author":"A Kumar","year":"2017","unstructured":"Kumar A, Jaryal A, Gulati S, Chakrabarty B, Singh A, Deepak KK, et al. Cardiovascular Autonomic Dysfunction in Children and Adolescents With Rett Syndrome. Pediatr Neurol. 2017;70:61\u20136.","journal-title":"Pediatr Neurol."},{"key":"1093_CR53","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1472-6963-14-89","volume":"14","author":"JP Domecq","year":"2014","unstructured":"Domecq JP, Prutsky G, Elraiyah T, Wang Z, Nabhan M, Shippee N, et al. Patient engagement in research: a systematic review. BMC Health Serv Res. 2014;14:89.","journal-title":"BMC Health Serv Res."},{"key":"1093_CR54","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/gt.2017.29","volume":"24","author":"D Julkowska","year":"2017","unstructured":"Julkowska D, Austin CP, Cutillo CM, Gancberg D, Hager C, Halftermeyer J, et al. The importance of international collaboration for rare diseases research: a European perspective. Gene Ther. 2017;24:562\u201371.","journal-title":"Gene Ther."},{"key":"1093_CR55","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1053\/j.semperi.2015.03.002","volume":"39","author":"BL Therrell","year":"2015","unstructured":"Therrell BL, Padilla CD, Loeber JG, Kneisser I, Saadallah A, Borrajo GJC, et al. Current status of newborn screening worldwide: 2015. Semin Perinatol. 2015;39:171\u201387.","journal-title":"Semin Perinatol."},{"key":"1093_CR56","unstructured":"Osborn R., Sarnak D. International Profiles of Health Care Systems. The Commonwealth Fund; 2016. Available from: \n                    http:\/\/wwww.issuelab.org\/resources\/25100\/25100.pdf\n                    \n                  . Accessed 23 November 2018."},{"key":"1093_CR57","unstructured":"Organization WH. Others. Tracking universal health coverage: 2017 global monitoring report: World Health Organization; 2017. Available from: \n                    http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/259817\/9789241513555-eng.pdf"},{"key":"1093_CR58","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1369-7625.2009.00567.x","volume":"13","author":"HM van de Bovenkamp","year":"2010","unstructured":"van de Bovenkamp HM, Trappenburg MJ, Grit KJ. Patient participation in collective healthcare decision making: the Dutch model. Health Expect. 2010;13:73\u201385.","journal-title":"Health Expect."}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1093-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1093-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1093-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T23:14:16Z","timestamp":1590621256000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1093-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,29]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1093"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1093-6","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,29]]},"assertion":[{"value":"29 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institutional Ethics Committee of the Institute of Bioinformatics and Applied Biotechnology, Bangalore (IBABIEC-04\/PR07\/010518). To indicate their consent to participate in the interviews, potential interviewees were asked to respond positively to an interview invitation sent by e-mail, and to sign an informed consent form. All the 19 interviewees did so.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Through an information sheet, all the interviewees were informed, inter alia, about the investigators\u2019 intention to publish the findings in an academic journal without seeking their approval of the manuscript. Although participants were assured that their responses would be kept confidential, subsequently, individual interviewees\u2019 permission was obtained to use particular information from the interviews in the intended publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"117"}}